In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
410 News Items found
MSK and Hartford leadership holding certificate
Announcement
MSK Cancer Alliance Grants Hartford HealthCare Cancer Institute Certified Member Status

The certification comes after a year in which hundreds of experts worked together to assess standards of care at Hartford HealthCare Cancer Institute.
Pictured: X-ray Image
In the Lab
New Findings Clarify How Kidney Cancer Spreads to Distant Organs

Scientists have identified genes and biological mechanisms that one day could be targeted with drugs to stop kidney cancer from spreading to the bone, brain, or other organs.
woman against grey background with her head in her hands
Feature
Coping with Shame Related to Cancer

Find out how to handle feelings of self-blame and shame that may accompany a cancer diagnosis.
MSK physician Dr. Deb Schrag
Experimental Blood Test for Cancer Shows Potential To Screen for Multiple Types Simultaneously

Learn how a blood test could someday provide a way to detect cancers at an early stage.
Surgeon William Jarnagin
Finding
Experimental Blood Test Uses EVP Proteins to Detect Cancer

Researchers report a new method that may enable detection of a number of different types of cancer in the early stages.
Woman pictured with son in EMT uniform and husband in firefighter uniform.
MSK Clinic Offers Pain Relief When Cancer Spreads to Bones

When Jacqueline was in pain caused by bone metastases from lung cancer, she got help at a specialized MSK clinic. "It's unbelievable the difference it made," she says.
Dr. Alexander Drilon speaks with a patient in an exam room
FDA Grants Full Approval to Targeted Therapy for Any Cancer With RET Gene Fusion

Selpercatinib has received full FDA approval for treating tumors anywhere in the body that harbor a genetic change called a RET fusion.
Harold Varmus former CEO of MSK
Harold Varmus: A Decade of Leadership at MSK

Harold Varmus became President and Chief Executive Officer of Memorial Sloan Kettering Cancer Center on January 1, 2000. He ended his decade-long tenure on July 1, 2010. And on July 12, 2010, Dr. Varmus took up a new role as Director of the National Cancer Institute.
Representative image of a dividing tumor cell showing the extrachromosomal location of duplicated BRAF genes
In the Lab
Giving Drugs Together — Rather than in Sequence — May Be Key to Halting Tumor Resistance

Scientists are learning how tumors develop resistance to drugs — and what can be done about it.
MSK investigators Joan Massagué and Anna Obenauf
In the Lab
Outsmarting Cancer’s Survival Skills

A new study led by MSK investigators reveals how some cancer cells become resistant to targeted treatment and suggests what might be done to stop that from happening.